GLAXOSMITH rounded off the 2019 financial year on a solid note, posting a year on year revenue growth of 12.76% to NGN20.76bn. As usual, the growth was spearheaded by revenue from the pharmaceutical division, up by 21.15% to NGN14.48bn. In the first quarter of 2020, the firm recorded a marginal moderation in its revenue year on year, down by 0.48% to NGN4.99bn.
Click on the link below to access the full report:
